Key facts
- S2N Health’s last known valuation is $5.2M (Jun 2025).
- It has raised $4.5M across 2 recorded rounds; the latest was Seed Round ($3.0M) in Mar 2026.
- Notable investors include Robin Hood Ventures, Boston Millennia Partners, Excelerate Health Ventures, Rittenhouse Ventures.
- S2N Health has filed 3 Form Ds with the SEC since 2023, most recently Jun 2025 ($4.3M sold to 34 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for S2N Health
Funding rounds
2 roundsAbout S2N Health
Operator of a consulting firm intended to provide business and marketing strategy support to the emerging medical technology community. The company's services include communications, informed business guidance, and market development support from product concept through early sales, full-service strategic marketing support, leveraging a network of like-minded practitioners in regulatory, reimbursement, and other disciplines to meet the needs of practical innovators, enabling healthcare firms to enhance growth and revenue through an entire suite of services.
- Sector
- Business Products and Services (B2B)
- HQ
- Boston, MA, United States
- Founded
- 2011
- Employees
- 31
- Website
- s2nhealth.com/
- Ownership
- Privately Held (backing)
S2N Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in S2N Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on S2N Health in its N-PORT filings yet. We sweep new filings monthly.